|Bid||0.0000 x 1800|
|Ask||0.0000 x 1200|
|Day's range||0.4010 - 0.4502|
|52-week range||0.3100 - 4.3800|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||N/A|
|Earnings date||07 Nov 2023 - 13 Nov 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.94|
SAN DIEGO, September 21, 2023--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration shareholder rights plan (the "Rights Plan") to protect the long-term interests of all shareholders. The Board adopted the Rights Plan in response to a rapid accumulation of shares by a third party. The Rights Plan is effective immediately and has a one-year term, expiring on September 20, 2024.
SAN DIEGO, August 23, 2023--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences:
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 3.77% and 10.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?